NCT07388524 2026-04-17Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC TrialNational Cancer Institute (NCI)Phase 3 Not yet recruiting336 enrolled
NCT07513324 2026-04-07Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)Dana-Farber Cancer InstitutePhase 2 Not yet recruiting116 enrolled
NCT07495735 2026-03-27Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular CarcinomaFirst Affiliated Hospital of Wenzhou Medical UniversityNot yet recruiting400 enrolled